Collaborative Fund Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Collaborative Fund Advisors's VRTX Position: Q3 2026 in Review
Collaborative Fund Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 107% in Q3 2026, buying an estimated $566K and bringing the position to 2,142 shares worth $1.12M. The position accounts for 0.6% of the portfolio, ranked #45.
Collaborative Fund Advisors first reported a position in VRTX in Q1 2026 and has held it in 3 quarters since. 1,787 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Collaborative Fund Advisors held 2,142 shares of Vertex Pharmaceuticals worth $1.12M as of Q3 2026.
- Collaborative Fund Advisors bought 1,106 Vertex Pharmaceuticals shares in Q3 2026, an estimated $566K.
- Vertex Pharmaceuticals made up 0.6% of Collaborative Fund Advisors's portfolio in Q3 2026, its #45 holding.
- Collaborative Fund Advisors first reported a position in Vertex Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- 1,787 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Collaborative Fund Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.